TrialEuropean journal of heart failure2025

Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial.

Jawad H Butt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.